Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Lut017
2. Lut-017
3. 2274819-49-5
4. 1,5-isoquinolinediamine, N1-(4-chloro-3-(trifluoromethyl)phenyl)-6-methyl-n5-(3-(9h-purin-6-yl)-2-pyridinyl)-
5. 1,5-isoquinolinediamine, N1-[4-chloro-3-(trifluoromethyl)phenyl]-6-methyl-n5-[3-(9h-purin-6-yl)-2-pyridinyl]-
6. Unii-qg9rvl7d9f
7. Schembl23015977
8. 1-n-[4-chloro-3-(trifluoromethyl)phenyl]-6-methyl-5-n-[3-(7h-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine
Molecular Weight | 546.9 g/mol |
---|---|
Molecular Formula | C27H18ClF3N8 |
XLogP3 | 6.5 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 5 |
Exact Mass | 546.1295048 g/mol |
Monoisotopic Mass | 546.1295048 g/mol |
Topological Polar Surface Area | 104 Ų |
Heavy Atom Count | 39 |
Formal Charge | 0 |
Complexity | 822 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A LUT017 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LUT017, including repackagers and relabelers. The FDA regulates LUT017 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LUT017 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A LUT017 supplier is an individual or a company that provides LUT017 active pharmaceutical ingredient (API) or LUT017 finished formulations upon request. The LUT017 suppliers may include LUT017 API manufacturers, exporters, distributors and traders.
LUT017 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LUT017 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right LUT017 GMP manufacturer or LUT017 GMP API supplier for your needs.
A LUT017 CoA (Certificate of Analysis) is a formal document that attests to LUT017's compliance with LUT017 specifications and serves as a tool for batch-level quality control.
LUT017 CoA mostly includes findings from lab analyses of a specific batch. For each LUT017 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LUT017 may be tested according to a variety of international standards, such as European Pharmacopoeia (LUT017 EP), LUT017 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LUT017 USP).
LOOKING FOR A SUPPLIER?